AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High...
AbbVie Declares Quarterly Dividend PR Newswire NORTH CHICAGO, Ill., Sept. 6, 2024 NORTH CHICAGO, Ill., Sept...
AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases PR Newswire NORTH...
SkinMedica® Revolutionizes Skin Hydration with the Introduction of HA5® Hydra Collagen Replenish + Restore...
European Commission Grants Second Indication Approval for TEPKINLY® (epcoritamab) for the Treatment of Adults...
AbbVie Completes Acquisition of Cerevel Therapeutics PR Newswire NORTH CHICAGO, Ill., Aug. 1, 2024 Cerevel's clinical-stage assets complement...
Allergan Aesthetics Celebrates the Second Annual JUVÉDERM® Day PR Newswire IRVINE, Calif., July 30, 2024 Join the seven million loyal Allē...
Toyota Motor (NYSE:TM) – Toyota’s global production fell 12.9% in June to 795,862 vehicles...
--INVOKE-2 is the first global Phase 2 trial evaluating the safety and efficacy of a TREM2 agonist, AL002, in...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.